D: Filing D
EFFECT: Others
424B3: Prospectus
CORRESP: CORRESP
UPLOAD: Others
S-3: Registration statement for specified transactions by certain issuers
8-K: Current report
S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
8-K: Dermata Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
10-Q: Q2 2024 Earnings Report
8-K: Current report
424B5: Prospectus
424B3: Prospectus
EFFECT: Others
CORRESP: CORRESP
UPLOAD: Others
S-3: Registration statement for specified transactions by certain issuers
8-K: Current report
424B5: Prospectus
8-K: Current report
No Data
No Data